Managing Respiratory Diseases: Updates from ERS 2024

Following the European Respiratory Society (ERS) congress 2024 in Vienna, Austria, Alberto Papi, Cedric “Jamie” Rutland and Cristina Gavina share which new areas of science grabbed their attention.

Following the European Respiratory Society (ERS) congress 2024 in Vienna, Austria, Alberto Papi, Cedric “Jamie” Rutland and Cristina Gavina share which new areas of science grabbed their attention. Some of the topics include:

• Burden of disease caused by respiratory pathogens, such as respiratory syncytial virus (RSV), and the impact on quality of life and healthcare systems
• New hot topics, such as refractory chronic cough (RCC), as well as discussion on viral pathogen-induced exacerbations of chronic respiratory conditions
• Perspectives on the management of respiratory comorbidities in patients with cardiovascular disease, and the benefit of cross-therapy area discussions and knowledge sharing
• Advances in knowledge and techniques that could be implemented in clinical practice, which will hopefully help to improve outcomes for millions of patients around the world

1. Professor of Respiratory Medicine at the University of Ferrara, Italy, and Director of the Respiratory Unit of the Department of Emergency Medicine, Saint Anna University Hospital, Ferrara, Italy
2. Pulmonary and Critical Care Physician, Rutland Medical Group, Newport Beach, California, USA
3. Director of the Medical Department and Cardiology Department at Hospital Pedro Hispano, Portugal

NX-GBL-GVU-VID-240055 | Date of preparation: October 2024

This content is developed and funded by GSK. © 2024 GSK group of companies. All rights reserved. Trademarks are owned by or licensed to the GSK group of companies. Intended for healthcare professionals only.